Series stock is trading -27.69% below its average target price of $38.77 after marking a 1.5% during today's afternoon session. Analysts are giving the Large-Cap Life Insurance company an average rating of buy and target prices ranging from $33.0 to $43.0 per share.
The stock has an average amount of shares sold short at 3.8%, and a short ratio of 2.53. The company's insiders own 0.35% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 98.3% of Series's shares being owned by this investor type.
Institutions Invested in Series
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2025-09-30 | Nippon Life Insurance Company | 23% | 121,956,256 | $3,419,043,618 |
| 2025-09-30 | American International Group, Inc. | 16% | 82,711,853 | $2,318,826,786 |
| 2025-09-30 | Blackstone Inc | 12% | 61,962,123 | $1,737,108,108 |
| 2025-09-30 | Price (T.Rowe) Associates Inc | 7% | 38,206,867 | $1,071,129,510 |
| 2025-09-30 | Vanguard Group Inc | 5% | 26,831,915 | $752,232,732 |
| 2025-09-30 | Pzena Investment Management LLC | 4% | 22,329,199 | $625,999,090 |
| 2025-09-30 | Harris Associates L.P. | 4% | 18,725,293 | $524,963,586 |
| 2025-09-30 | Massachusetts Financial Services Co. | 2% | 8,160,918 | $228,791,334 |
| 2025-09-30 | Canada Pension Plan Investment Board | 2% | 7,939,129 | $222,573,480 |
| 2025-09-30 | State Street Corporation | 2% | 7,830,321 | $219,523,048 |
Besides an analyst consensus of strong upside potential, other market factors point to there being mixed market sentiment on Series.
